AGP Executive Report
Last update: 10 hours agoSickle Cell Care in Focus: Senegal has launched West Africa’s first locally made sickle cell drug, Drepaf, a generic hydroxyurea produced by Dakar’s Teranga Pharma to cut costs and reduce reliance on imports, with reported supply interest from Burkina Faso, Guinea, Côte d’Ivoire—and requests from Cameroon, Gabon and the DRC. Health Financing Ideas: A new push on debt-for-development swaps highlights how countries can redirect debt savings into health priorities, including Africa examples tied to education, climate resilience, and “debt-for-nature” deals that also reach health programmes. Gabon Health Funding: Gabon’s ruling RPM coalition praised President Oligui Nguema’s 21-day push, pointing to a major August 30 health pledge of 55 billion CFA francs for upgrading medical facilities, reopening hospital cafeterias, and boosting CNAMGS services. Regional Trade & Health Risks: Cameroon’s customs extended its crackdown on fraud and smuggling in Kribi and Campo, targeting illegal drinks and frozen foods—an effort framed around protecting consumers and local businesses from unsafe, untaxed imports. Policy/Access Tech (Elsewhere): Tobago launched a digital ID (Tobago ID) to streamline access to services including health care, tying uptake to a baby grant requirement.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.